A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy

PURPOSE: Programmed death ligand 1 (PD-L1) has been proposed as an important prognostic factor in many types of cancer. However, the role of predicting the prognosis of PD-L1 in extranodal natural killer/T-cell lymphoma (ENKTL) was controversial. Combining other biomarkers might enhance its predicti...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Manag Res
Prif Awduron: Lam, Sio Teng, Huang, He, Fang, Xiaojie, Wang, Zhao, Hong, Huangming, Ren, Quanguang, Tian, Ying, Lin, Suxia, Lin, Tongyu
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove 2020
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7085340/
https://ncbi.nlm.nih.gov/pubmed/32231439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S244176
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg